Apixaban for the treatment of acute splanchnic vein thrombosis: A pilot study

•Direct oral anticoagulants lack data for splanchnic vein thrombosis (SVT).•This study explores the role of apixaban in SVT.•This study enrolled 23 patients with acute SVT and assessed their bleeding risk.•Apixaban was effective for SVT, but caution is required in liver cirrhosis.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thrombosis research 2024-05, Vol.237, p.181-183
Hauptverfasser:	Kim, Sang-A, Choi, Gwang Hyeon, Lee, Ji Yun, Jang, Eun Sun, Lee, Jeong-Ok, Kim, Jin-Wook, Jeong, Sook-Hyang, Bang, Soo-Mee
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Adult Aged Anticoagulation Apixaban Direct oral anticoagulant Factor Xa Inhibitors - therapeutic use Female Humans Liver cirrhosis Male Middle Aged Pilot Projects Pyrazoles - therapeutic use Pyridones - therapeutic use Splanchnic Circulation - drug effects Splanchnic vein thrombosis Venous Thrombosis - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	•Direct oral anticoagulants lack data for splanchnic vein thrombosis (SVT).•This study explores the role of apixaban in SVT.•This study enrolled 23 patients with acute SVT and assessed their bleeding risk.•Apixaban was effective for SVT, but caution is required in liver cirrhosis.
ISSN:	0049-3848 1879-2472
DOI:	10.1016/j.thromres.2024.04.002